Market Place
Sourcing Support
Aktis Presents First Clinical Data For AKY-1189 At Symposium
24 Oct 2024 //
PR NEWSWIRE
Lilly-partnered radiopharma startup Aktis Oncology raises $175M
01 Oct 2024 //
BIOPHARMADIVE
Aktis Oncology To Attend Morgan Stanley Healthcare Conference
28 Aug 2024 //
PR NEWSWIRE
AKTIS ONCOLOGY APPOINTS AKOS CZIBERE, MD, PhD, CHIEF MEDICAL OFFICER
09 Jul 2024 //
PR NEWSWIRE
Aktis Oncology Expands Board With Nuclear Medicine Expert Ken Herrmann
13 Jun 2024 //
PR NEWSWIRE
Aktis Oncology At Radiopharmaceutical Innovation Summit By TD Cowen
10 Jun 2024 //
PR NEWSWIRE
Aktis to collaborate with Eli Lilly on cancer therapies
22 May 2024 //
REUTERS
AKTIS, Lilly Partner On Novel Anticancer Radiopharmaceuticals
21 May 2024 //
PR NEWSWIRE
AKTIS At Guggenheim Healthcare Radiopharmaceuticals Talk
09 May 2024 //
PR NEWSWIRE
Aktis Oncology To Participate In The Td Cowen 44Th Annual Healthcare Conference
28 Feb 2024 //
PR NEWSWIRE
Aktis Oncology Expands Scientific Advisory Board
15 Jun 2023 //
PR NEWSWIRE
AKTIS ONCOLOGY TO PARTICIPATE IN THE COWEN 43RD ANNUAL HEALTHCARE CONFERENCE
06 Mar 2023 //
PR NEWSWIRE
Aktis Oncology Appoints Shulamit Ron-Bigger As Chief Operating Officer
19 Sep 2022 //
PRNEWSWIRE
Aktis makes waves with $84M extension
26 Aug 2022 //
FIERCEBIOTECH
Aktis Oncology Announces Actinium-225 Supply Agreements with Isotope Producers
23 Aug 2022 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.